Triptans for acute cluster headache

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 7, 2013, Pages

  Law, Simon ^a   Derry, Sheena ^b   Moore, R Andrew ^b  

^a GLOUCESTERSHIRE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SUMATRIPTAN; ZOLMITRIPTAN; OXAZOLIDINONE DERIVATIVE; SEROTONIN AGONIST; TRYPTAMINE DERIVATIVE;

ADVERSE OUTCOME; ANALGESIA; BODY TEMPERATURE DISORDER; CHRONIC CLUSTER HEADACHE; CLINICAL EFFECTIVENESS; DISEASE DURATION; DIZZINESS; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; DYSPNEA; EPISODIC CLUSTER HEADACHE; ERYTHEMA; FATIGUE; HUMAN; INJECTION SITE REACTION; INTENTION TO TREAT ANALYSIS; MALAISE; META ANALYSIS; MUSCLE RIGIDITY; MUSCLE TIGHTNESS; NAUSEA; PAIN; PAIN INTENSITY; PAIN SEVERITY; PARALYSIS; PARESTHESIA; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SIDE EFFECT; SKIN TINGLING; SOMNOLENCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; VISUAL ANALOG SCALE; VOMITING; CLUSTER HEADACHE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CLUSTER HEADACHE; HUMANS; OXAZOLIDINONES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN RECEPTOR AGONISTS; SUMATRIPTAN; TRYPTAMINES;

EID: 84891655117     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008042.pub3     Document Type: Review

References (45)

1. Bahra A, Gawel MJ, Hardebo JE, Millson D, Breen SA, Goadsby PJ. Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology 2000;54(9):1832-9.
2. Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ. Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Archives of Neurology 2006;63(11):1537-42. [DOI: 10.1001/archneur.63.11.nct60002]
3. The Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. New England Journal of Medicine 1991;325(5):322-6.
4. Ekbom K, Monstad I, Prusinski A, Cole JA, Pilgrim AJ, Noronha D. Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group. Acta Neurologica Scandinavica 1993;88(1):63-9.
5. Rapoport AM, Mathew NT, Silberstein SD, Dodick D, Tepper SJ, Sheftell FD, et al. Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study. Neurology 2007;69(9):821-6. [DOI: 10.1212/01.wnl.0000267886.85210.37]
6. Van Vliet JA, Bahra A, Martin V, Ramadan N, Aurora SK, Mathew NT, et al. Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study. Neurology 2003;60(4):630-3.
7. Goadsby PJ. The clinical profile of sumatriptan: cluster headache. European Neurolology 1994;34 Suppl 2:35-9.
8. Hardebo JE, Dahlöf C. Sumatriptan nasal spray (20 mg/dose) in the acute treatment of cluster headache. Cephalalgia 1998;18(7):487-9.
9. Bennett MH, French C, Schnabel A, Wasiak J, Kranke P. Normobaric and hyperbaric oxygen therapy for migraine and cluster headache. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD005219.pub2]
10. The Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. New England Journal of Medicine 1991;325(5):322-6.
11. Cohen A, Burns B, Goadsby P. High flow oxygen for the treatment of cluster headache: a randomised, placebo controlled trial. JAMA 2009;302(22):2451-7.
12. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995;310(6977):452-4.
13. D'Alessandro R, Gamberini G, Benassi G, Morganti G, Cortelli, Lugaresi E. Cluster headache in the Republic of San Marino. Cephalalgia 1986;6(3):159-62.
14. Derry C, Derry S, Moore RA, McQuay HJ. Single dose oral ibuprofen for acute postoperative pain in adults. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD001548.pub2]
15. Dodick DW, Martin VT, Smith T, Silberstein S. Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache 2004;44 Suppl 1:S20-30.
16. Ekbom K, Ahlborg B, Schéle R. Prevalence of migraine and cluster headache in Swedish men of 18. Headache 1978;18(1):9-19.
17. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9. [DOI: 10.1093/ije/31.1.140]
18. Göbel H, Lindner V, Heinze A, Ribbat M, Deuschl G. Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study. Neurology 1998;51(3):908-11.
19. Hedlund C, Rapoport AM, Dodick DW, Goadsby PJ. Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies. Headache 2009;49(9):1315-23. [DOI: 10.1111/j.1526-4610.2009.01518.x]
20. Higgins JPT, Green S (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Altman DG, Sterne JAC editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
21. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:1-96.
22. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 2nd edition. Cephalalgia 2004;24 Suppl 1:1-160.
23. Lipton RB, Micieli G, Russell D, Solomon S, Tfelt-Hansen P, Waldenlind E, for the International Headache Society Committee on Clinical Trials in Cluster Headache. Guidelines for controlled trials of drugs in cluster headache. Cephalalgia 1995;15(6):452-62.
24. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomised controlled trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
25. L'Abbé KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Annals of Internal Medicine 1987;107(2):224-33.
26. May A, Bahra A, Büchel C, Frackowiak RS, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet 1998;352(9124):275-8.
27. McAlister FA, Sackett DL. Active-control equivalence trials and antihypertensive agents. American Journal of Medicine 2001;111(7):553-8.
28. Moore RA, Gavaghan D, Tramer MR, Collins SL, McQuay HJ. Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;78(3):209-16.
29. Moore A, Edwards J, Barden J, McQuay H. Bandolier's little book of pain. Oxford: Oxford University Press, 2003.
30. Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15-24. [ISBN: 978-0-931092-69-5]
31. Moore RA, Eccleston C, Derry S, Wiffen P, Bell RF, Straube S, et al. "Evidence" in chronic pain - establishing best practice in the reporting of systematic reviews. Pain 2010;150(3):386-9. [DOI: 10.1016/j.pain.2010.05.011]
32. Morris JA, Gardner MJ. Calculating confidence intervals for relative risk, odds ratio and standardized ratios and rates. Gardner MJ, Altman DG, editors(s). Statistics with confidence - confidence intervals and statistical guidelines. London: British Medical Journal, 1995:50-63.
33. Nesbitt AD, Goadsby PJ. Cluster headache. BMJ 2012;344:e2407. [DOI: 10.1136/bmj.e2407]
34. Plosker GL, McTavish D. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 1994;47(4):622-51.
35. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
36. Rozen TD, Fishman RS. Inhaled oxygen and cluster headache sufferers in the United States: use, efficacy and economics: results from the United States Cluster Headache Survey. Headache 2011;51(2):191-200. [DOI: 10.1111/j.1526-4610.2010.01806.x]
37. Russell MB. Epidemiology and genetics of cluster headache. Lancet Neurology 2004;3(5):279-83. [DOI: 10.1016/S1474-4422(04)00735-5]
38. Sjöstrand C, Russell MB, Ekbom K, Waldenlind E. Familial cluster headache: demographic patterns in affected and nonaffected. Headache 2010;50(3):374-82. [DOI: 10.1111/j.1526-4610.2009.01426.x]
39. Tepper SJ, Millson D. Safety profile of the triptans. Expert Opinion on Drug Safety 2003;2(2):123-32.
40. Tfelt-Hansen PC, Jensen RH. Management of cluster headache. CNS Drugs 2012;27(7):571-80. [DOI: 10.2165/11632850-000000000-00000]
41. Torelli P, Beghi E, Manzoni GC. Cluster headache prevalence in the Italian general population. Neurology 2005;64(3):469-74.
42. Tramèr MR, Reynolds DJM, Moore RA, McQuay HJ. Impact of covert duplicate results on meta-analysis: a case study. BMJ 1997;315(7109):635-40.
43. Tyagi A, Matharu M. Evidence base for the medical treatments used in cluster headache. Current Pain and Headache Reports 2009;13(2):168-78.
44. Welch KM, Mathew NT, Stone P, Rosamond W, Saiers J, Gutterman D. Tolerability of sumatriptan: clinical trials and post-marketing experience. Cephalalgia 2000;20(8):687-95.
45. Law S, Derry S, Moore RA. Triptans for acute cluster headache. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD008042.pub2]